10decodersInsights for US healthcare firms building in India.
Practical, founder-to-founder writing on how to enter India well — BOT vs Pod vs staff-aug, what "HIPAA-grade" really means offshore, and why the mid-market is under-served. No fluff, no demo bait.
How US healthcare firms should enter India
The three entry models aren't sizes of the same thing — they carry risk differently and leave you owning different things. A clear-eyed framework for choosing your starting rung, written for founders, not procurement.
Notify me when it's liveWhat "HIPAA-grade" really means for an offshore team
Beyond the badge: the controls, the BAA timing, and the operating habits that separate real healthcare compliance from a checklist.
The mid-market GCC playbook — and why the giants under-serve it
The 10–40 seat healthcare wedge the large integrators can’t economically attend to, and how to win in it.
Retention is the make-or-break of any India captive
Why attrition quietly destroys offshore value, and what a retention culture that survives a transfer actually looks like.
CMS-0057-F & the compressed-timeline pressure
A GCC analogue: how interoperability deadlines change the build-vs-buy math for health-tech engineering capacity.
Building DocuFindr from Chennai: what it taught us about captives
The lessons from standing up our own US-grade product org — and how they shape the way we build yours.
Authority, not advertising.
These posts are written to be genuinely useful to a healthcare founder weighing an India center — the kind of thing you'd want a peer who'd already done it to tell you over coffee.
